Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Effects of Coenzyme Q10 Administration on Blood Pressure and Heart Rate in Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Publisher



Karimi M1 ; Pirzad S2 ; Hooshmand F3 ; Shirsalimi N4 ; Pourfaraji SMA5
Authors
Show Affiliations
Authors Affiliations
  1. 1. Faculty of Medicine, Bogomolets National Medical University (NMU), Kyiv, Ukraine
  2. 2. Faculty of Medicine, Islamic Azad University, Tehran Medical Sciences Branch (IAUTMU), Tehran, Iran
  3. 3. Faculty of Medicine, Golestan University of Medical Sciences, Gorgan, Iran
  4. 4. Faculty of Medicine, Hamadan University of Medical Sciences (UMSHA), Hamadan, Iran
  5. 5. Faculty of Medicine, Tehran University of Medical Sciences (TUMS), Tehran, Iran

Source: International Journal of Cardiology: Cardiovascular Risk and Prevention Published:2025


Abstract

Background and objective: Coenzyme Q10 is a naturally occurring antioxidant that has been suggested to improve cardiovascular health. Studies examining the effects of Q10 on blood pressure (BP) and heart rate (HR) have found inconsistent results. This meta-analysis aims to clarify the effects of Q10 administration on BP and HR in adults. Methods: A comprehensive search of online databases was conducted until February 2025 to identify relevant randomized controlled trials (RCTs). Following screening, relevant data were extracted from the eligible studies. Statistical analyses were conducted using weighted mean differences (WMD) with 95 % confidence intervals (CI). Data analysis was performed using the “meta” package in R. Results: The pooled analysis of 45 RCTs (48 effect sizes) showed that Q10 administration significantly reduced systolic BP (WMD: −3.44 mmHg; 95 %CI: [-5.13 to −1.55], p < 0.01), while no significant effect was observed on diastolic BP (WMD: −1.13 mmHg; 95 %CI: [-2.16 – 0.50], p = 0.23) and HR (WMD: −0.10 bpm; 95 %CI: [-2.09 – 1.89], p = 0.44). Subgroup analysis indicated that lower doses (<200 mg/day) and longer interventions (>8 weeks) resulted in greater systolic BP reductions. Conclusion: This meta-analysis indicates that CoQ10 supplementation may be an effective adjunctive therapy for reducing systolic blood pressure, especially at doses below 200 mg/day and with longer treatment durations. However, its impact on diastolic blood pressure and heart rate appears minimal. Given its favorable safety profile, CoQ10 could be considered as a supportive option in the management of hypertension, particularly for patients seeking non-pharmacological interventions or those with mild elevations in systolic BP. © 2025 The Authors
Related Docs
1. Effect of Coenzyme Q10 Supplementation on Diabetes Biomarkers: A Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials, Archives of Iranian Medicine (2016)
2. Coenzyme Q10 Supplementation and Oxidative Stress Parameters: A Systematic Review and Meta-Analysis of Clinical Trials, European Journal of Clinical Pharmacology (2020)
3. Coenzyme Q10 in the Treatment of Heart Failure: A Systematic Review of Systematic Reviews, Indian Heart Journal (2018)
4. Reduction in Asymmetric Dimethylarginine Plasma Levels by Coenzyme Q10 Supplementation in Patients With Type 2 Diabetes Mellitus, Minerva Endocrinologica (2015)
5. Effects of Coenzyme Q10 on Health-Related Quality of Life, Clinical Disease Activity and Blood Pressure in Patients With Mild to Moderate Ulcerative Colitis: A Randomized Clinical Trial, Medical Journal of the Islamic Republic of Iran (2021)
6. The Effect of Coenzyme Q10 Supplementation on Circulating Levels of Novel Adipokine Adipolin/Ctrp12 in Overweight and Obese Patients With Type 2 Diabetes, Experimental and Clinical Endocrinology and Diabetes (2017)
Experts (# of related papers)
View all Related Experts
Mohammad Javad Hosseinzadeh Attar (2)
Alireza Esteghamati (2)